1724/2013 - Há irracionalidades no consumo de inibidores de apetite no Brasil? Uma análise farmacoeconométrica de dados em painel Is there irrational use of anti-obesity drugs in Brazil? An analysis of panel data pharmacoeconometric
• José Angelo Divino - Divino, J.A. - Universidade Católica de Brasília - <jangelo@pos.ucb.br>
Área Temática:
Políticas em Saúde
Resumo:
Este estudo busca analisar os determinantes do consumo de inibidores de apetite (anfepramona, femproporex, mazindol e sibutramina) por meio da estimação de um modelo dinâmico de dados em painel para as capitais brasileiras e do Distrito Federal (DF) no período de 2009 a 2011. Os resultados revelam que o consumo de inibidores de apetite não acompanhou a distribuição geográfica dos indivíduos com excesso de peso e com obesidade nas unidades estudadas. Há um consumo recorrente de inibidores em que 79% do consumo atual desses fármacos é explicado pelo consumo passado. Dentre as variáveis que explicam o consumo de inibidores, destacam-se o percentual de adultos com obesidade, o percentual de adultos que consomem frutas e hortaliças e a taxa de cobertura de planos de saúde. A análise farmacoeconométrica sugere que há problemas no uso racional dos inibidores de apetite nas capitais brasileiras e no DF, seja no que tange ao consumo desses medicamentos com outros fármacos – considerados ilegais pelo Conselho Federal de Medicina e pela Anvisa – e, também, na indicação terapêutica de uso desses produtos.
Palavras-chave:
Análise de regressão
economia farmacêutica
depressores do apetite
obesidade
Abstract:
The goal of this study is to analyze the determinants of the use of appetite suppressants (amfepramone, femproporex, mazindol and sibutramine) through the estimation of a dynamic panel data model for the Brazilian state capitals and the Federal District (DF) in the period from 2009 to 2011. The results show that consumption of appetite suppressants did not follow the geographic distribution of individuals with overweight and obesity across the capitals and DF. There is a recurrent consumption of appetite inhibitors, in which 79% of the current consumption of these drugs is explained by past consumption. Among the variables that explain the use of inhibitors, we highlight the percentage of obese adults, the percentage of adults who habitually consume fruits and vegetables, and coverage rate of health plans. The pharmacoeconometric analysis suggests that there are problems in the rational use of appetite suppressants in the Brazilian state capitals and the Federal District regarding to both the combined consumption of these drugs with other medicines - deemed illegal by the Federal Council of Medicine and ANVISA - and in the therapeutic indication of these products.
Is there irrational use of anti-obesity drugs in Brazil? An analysis of panel data pharmacoeconometric
Resumo (abstract):
The goal of this study is to analyze the determinants of the use of appetite suppressants (amfepramone, femproporex, mazindol and sibutramine) through the estimation of a dynamic panel data model for the Brazilian state capitals and the Federal District (DF) in the period from 2009 to 2011. The results show that consumption of appetite suppressants did not follow the geographic distribution of individuals with overweight and obesity across the capitals and DF. There is a recurrent consumption of appetite inhibitors, in which 79% of the current consumption of these drugs is explained by past consumption. Among the variables that explain the use of inhibitors, we highlight the percentage of obese adults, the percentage of adults who habitually consume fruits and vegetables, and coverage rate of health plans. The pharmacoeconometric analysis suggests that there are problems in the rational use of appetite suppressants in the Brazilian state capitals and the Federal District regarding to both the combined consumption of these drugs with other medicines - deemed illegal by the Federal Council of Medicine and ANVISA - and in the therapeutic indication of these products.
Mota, D.M, Oliveira, MG, Bovi, R.F., Silva, S.F., Divino, J.A.. Há irracionalidades no consumo de inibidores de apetite no Brasil? Uma análise farmacoeconométrica de dados em painel. Cien Saude Colet [periódico na internet] (2013/dez). [Citado em 24/12/2024].
Está disponível em: http://cienciaesaudecoletiva.com.br/artigos/ha-irracionalidades-no-consumo-de-inibidores-de-apetite-no-brasil-uma-analise-farmacoeconometrica-de-dados-em-painel/14918?id=14918&id=14918
